Insider transactions

EDGAR

RELMADA THERAPEUTICS, INC.

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.

A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.

Window: transactions dated on or after 2025-11-21.

Open-market purchases (code P)
6 transactions, 439,165 shares
Sum of shares × price per share: 1,833,349.8
Open-market sales (code S)
0 transactions, — shares

Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.

Showing 1–13 of 13

Insider transactions, newest first, as filed on SEC Forms 3, 4 and 5
DateReporting ownerCodeAcquired or disposedSharesPrice per share, as filedValue (derived)Shares owned afterDirect or indirectRule 10b5-1 boxNotesSource
2026-09-10 Filed 2026-09-11TRAVERSA SERGIO Director · Officer: Chief Executive Officer
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)100,0004.1
410,000

Derived: shares × price per share. Exact value 410000.0.

1,500,000Direct (D) No
F1, F3
  • F1 The number of securities reported represents an aggregate number of shares purchased in multiple open market transactions over a range of purchase prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares purchased by the Reporting Person at each separate price within the range.
  • F3 Purchase prices range from $4.03 to $4.11 per share, inclusive
Open filing 0001213900-26-098969 Read from the filing’s XML Dispute this row
2026-09-10 Filed 2026-09-11Shenouda Maged Officer: Chief Financial Officer
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)79,8004.25
339,150

Derived: shares × price per share. Exact value 339150.00.

1,000,000Direct (D) No— Open filing 0001213900-26-098970 Read from the filing’s XML Dispute this row
2026-09-09 Filed 2026-09-11TRAVERSA SERGIO Director · Officer: Chief Executive Officer
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)100,0004.18
418,000

Derived: shares × price per share. Exact value 418000.00.

1,400,000Direct (D) No
F1, F2
  • F1 The number of securities reported represents an aggregate number of shares purchased in multiple open market transactions over a range of purchase prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares purchased by the Reporting Person at each separate price within the range.
  • F2 Purchase prices range from $4.15 to $4.22 per share, inclusive.
Open filing 0001213900-26-098969 Read from the filing’s XML Dispute this row
2026-09-09 Filed 2026-09-11Shenouda Maged Officer: Chief Financial Officer
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)120,2004.20
504,840

Derived: shares × price per share. Exact value 504840.00.

920,200Direct (D) No
F1, F2
  • F1 The number of securities reported represents an aggregate number of shares purchased in multiple open market transactions over a range of purchase prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares purchased by the Reporting Person at each separate price within the range.
  • F2 Purchase prices range from $4.16 to $4.20 per share, inclusive.
Open filing 0001213900-26-098970 Read from the filing’s XML Dispute this row
2025-12-15 Filed 2025-12-16Shenouda Maged Officer: Chief Financial Officer
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)11,6654.12
48,059.8

Derived: shares × price per share. Exact value 48059.80.

800,000Direct (D) No— Open filing 0001213900-25-121973 Read from the filing’s XML Dispute this row
2025-12-15 Filed 2025-12-16TRAVERSA SERGIO Director · Officer: Chief Executive Officer
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)27,5004.12
113,300

Derived: shares × price per share. Exact value 113300.00.

1,300,000Direct (D) No
F1, F2
  • F1 The number of securities reported represents an aggregate number of shares purchased in multiple open market transactions over a range of purchase prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares purchased by the Reporting Person at each separate price within the range.
  • F2 Purchase prices range from $4.10 to $4.12 per share, inclusive.
Open filing 0001213900-25-121974 Read from the filing’s XML Dispute this row
2025-12-12 Filed 2025-12-16GLASSPOOL JOHN Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Appreciation Rights — underlying Common Stock (164,000) — exercise price 4.06
Acquired (A)164,0000—164,000Direct (D) No
F1
  • F1 The stock appreciation rights vest in 16 equal quarterly installments commencing on March 12, 2026.
Open filing 0001213900-25-121969 Read from the filing’s XML Dispute this row
2025-12-12 Filed 2025-12-16Kelly Paul Edward Director · Officer: COO
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Appreciation Rights — underlying Common Stock (828,000) — exercise price 4.06
Acquired (A)828,0000—828,000Direct (D) No
F1
  • F1 The stock appreciation rights vest in 16 equal quarterly installments commencing on March 12, 2026.
Open filing 0001213900-25-121968 Read from the filing’s XML Dispute this row
2025-12-12 Filed 2025-12-16Shenouda Maged Officer: Chief Financial Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Appreciation Rights — underlying Common Stock (828,000) — exercise price 4.06
Acquired (A)828,0000—828,000Direct (D) No
F1
  • F1 The stock appreciation rights vest in 16 equal quarterly installments commencing on March 12, 2026.
Open filing 0001213900-25-121973 Read from the filing’s XML Dispute this row
2025-12-12 Filed 2025-12-16Ence Chuck Officer: CA and CO
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Appreciation Rights — underlying Common Stock (828,000) — exercise price 4.06
Acquired (A)828,0000—828,000Direct (D) No
F1
  • F1 The stock appreciation rights vest in 16 equal quarterly installments commencing on March 12, 2026.
Open filing 0001213900-25-121972 Read from the filing’s XML Dispute this row
2025-12-12 Filed 2025-12-16Fedeli Fabiana Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Appreciation Rights — underlying Common Stock (164,000) — exercise price 4.06
Acquired (A)164,0000—164,000Direct (D) No
F1
  • F1 The stock appreciation rights vest in 16 equal quarterly installments commencing on March 12, 2026.
Open filing 0001213900-25-121971 Read from the filing’s XML Dispute this row
2025-12-12 Filed 2025-12-16CASAMENTO CHARLES J Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Appreciation Rights — underlying Common Stock (164,000) — exercise price 4.06
Acquired (A)164,0000—164,000Direct (D) No
F1
  • F1 The stock appreciation rights vest in 16 equal quarterly installments commencing on March 12, 2026.
Open filing 0001213900-25-121967 Read from the filing’s XML Dispute this row
2025-12-12 Filed 2025-12-16TRAVERSA SERGIO Director · Officer: Chief Executive Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Appreciation Rights — underlying Common Stock (1,198,000) — exercise price 4.06
Acquired (A)1,198,0000—1,198,000Direct (D) No
F3
  • F3 The stock appreciation rights vest in 16 equal quarterly installments commencing on March 12, 2026.
Open filing 0001213900-25-121974 Read from the filing’s XML Dispute this row

Institutional holders (Form 13F)

Quarter ending 2026-09-30: 8,935 filings read, the latest filed 2026-11-20. Prior quarter ending 2026-06-30: 9,178 filings read.

Showing 1–50 of 142

Institutional holders, largest position first, as filed
ManagerShares or principalValue as filedChange from the prior quarterSource
Janus Henderson Group Ltd. Partly reported under another manager11,164,803 SH42,035,483 dollarsNot in the prior quarter’s filings read Open filing 0001085146-26-000952 Filed 2026-11-16 Dispute this row
BlackRock, Inc. Partly reported under another manager7,576,990 SH28,565,252 dollarsHigher by 150,210 Prior quarter: 7,426,780Open filing 0002012383-26-003985 Filed 2026-11-13 Dispute this row
Venrock Adviser, LLC 7,445,050 SH28,067,839 dollarsHigher by 600,745 Prior quarter: 6,844,305Open filing 0001615982-26-000019 Filed 2026-11-16 Dispute this row
Spruce Street Capital LP 6,912,191 SH26,058,960 dollarsHigher by 520,863 Prior quarter: 6,391,328Open filing 0002050194-26-000006 Filed 2026-11-13 Dispute this row
Jones Hill Capital LP 5,237,628 SH19,745,858 dollarsHigher by 1,582,553 Prior quarter: 3,655,075Open filing 0002102314-26-000006 Filed 2026-11-13 Dispute this row
ADAGE CAPITAL PARTNERS GP, L.L.C. 4,763,158 SH17,957,106 dollarsUnchanged Prior quarter: 4,763,158Open filing 0001172661-26-005200 Filed 2026-11-16 Dispute this row
VANGUARD CAPITAL MANAGEMENT LLC 4,357,967 SH16,429,536 dollarsLower by 102,243 Prior quarter: 4,460,210Open filing 0002100119-26-001711 Filed 2026-11-13 Dispute this row
AMERIPRISE FINANCIAL INC Partly reported under another manager3,722,041 SH14,032,095 dollarsHigher by 1,784,069 Prior quarter: 1,937,972Open filing 0001193125-26-463125 Filed 2026-11-16 Dispute this row
Sio Capital Management, LLC 3,629,844 SH13,684,512 dollarsHigher by 2,626,282 Prior quarter: 1,003,562Open filing 0001214659-26-014302 Filed 2026-11-16 Dispute this row
Squadron Capital Management LLC 3,500,000 SH13,195,000 dollarsLower by 3,850,000 Prior quarter: 7,350,000Open filing 0002050709-26-000036 Filed 2026-11-16 Dispute this row
MILLENNIUM MANAGEMENT LLC 3,345,573 SH12,612,810 dollarsHigher by 983,746 Prior quarter: 2,361,827Open filing 0001273087-26-000011 Filed 2026-11-16 Dispute this row
STATE STREET CORP Partly reported under another manager3,309,355 SH12,476,268 dollarsHigher by 791,805 Prior quarter: 2,517,550Open filing 0000093751-26-000747 Filed 2026-11-12 Dispute this row
GEODE CAPITAL MANAGEMENT, LLC Partly reported under another manager2,361,437 SH8,905,276 dollarsLower by 131,136 Prior quarter: 2,492,573Open filing 0001214717-26-000012 Filed 2026-11-06 Dispute this row
Commodore Capital LP 2,350,000 SH8,859,500 dollarsHigher by 925,000 Prior quarter: 1,425,000Open filing 0001831942-26-000052 Filed 2026-11-16 Dispute this row
FRANKLIN TEMPLETON INC Partly reported under another manager2,248,263 SH9,375,257 dollarsNot in the prior quarter’s filings read Open filing 0000038777-26-000291 Filed 2026-11-12 Dispute this row
Driehaus Capital Management LLC 2,132,053 SH8,037,840 dollarsUnchanged Prior quarter: 2,132,053Open filing 0000938206-26-000066 Filed 2026-11-16 Dispute this row
Qube Research Technologies Ltd 1,911,342 SH7,205,759 dollarsHigher by 1,219,797 Prior quarter: 691,545Open filing 0001729829-26-000018 Filed 2026-11-13 Dispute this row
EVENTIDE ASSET MANAGEMENT, LLC 1,858,416 SH7,006,228 dollarsUnchanged Prior quarter: 1,858,416Open filing 0001580642-26-007711 Filed 2026-11-13 Dispute this row
ORBIMED ADVISORS LLC 1,670,079 SH6,296,198 dollarsLower by 1,961,116 Prior quarter: 3,631,195Open filing 0001172661-26-005349 Filed 2026-11-16 Dispute this row
Balyasny Asset Management L.P. 1,503,760 SH5,669,175 dollarsLower by 16,928 Prior quarter: 1,520,688Open filing 0001193125-26-463223 Filed 2026-11-16 Dispute this row
Ikarian Capital, LLC 1,448,359 SH5,460,313 dollarsLower by 700,000 Prior quarter: 2,148,359Open filing 0001420506-26-002881 Filed 2026-11-16 Dispute this row
Polar Capital Holdings Plc Partly reported under another manager1,336,318 SH5,037,919 dollarsLower by 4,110 Prior quarter: 1,340,428Open filing 0001172661-26-005169 Filed 2026-11-16 Dispute this row
VANGUARD PORTFOLIO MANAGEMENT LLC 1,180,661 SH4,451,092 dollarsHigher by 282,463 Prior quarter: 898,198Open filing 0002100121-26-001150 Filed 2026-11-13 Dispute this row
Walleye Capital LLC 1,015,489 SH3,828,394 dollarsHigher by 399,251 Prior quarter: 616,238Open filing 0001758720-26-000007 Filed 2026-11-13 Dispute this row
Opaleye Management Inc. 1,000,000 SH3,770,000 dollarsHigher by 65,000 Prior quarter: 935,000Open filing 0001420506-26-002880 Filed 2026-11-16 Dispute this row
Corient Private Wealth LP 912,915 SH3,441,690 dollarsHigher by 193,333 Prior quarter: 719,582Open filing 0001948780-26-000012 Filed 2026-11-16 Dispute this row
GOLDMAN SACHS GROUP INC Partly reported under another manager880,889 SH3,320,954 dollarsHigher by 113,265 Prior quarter: 767,624Open filing 0000886982-26-000647 Filed 2026-11-16 Dispute this row
GREAT POINT PARTNERS LLC Partly reported under another manager842,106 SH3,174,740 dollarsUnchanged Prior quarter: 842,106Open filing 0001172661-26-005345 Filed 2026-11-16 Dispute this row
NORTHERN TRUST CORP Partly reported under another manager759,502 SH2,863,323 dollarsLower by 26,755 Prior quarter: 786,257Open filing 0000073124-26-000067 Filed 2026-11-16 Dispute this row
VANGUARD FIDUCIARY TRUST CO 690,663 SH2,603,800 dollarsLower by 43,528 Prior quarter: 734,191Open filing 0000933478-26-000017 Filed 2026-11-13 Dispute this row
AdvisorShares Investments LLC 670,861 SH2,529,146 dollarsHigher by 231,960 Prior quarter: 438,901Open filing 0001829126-26-012138 Filed 2026-11-09 Dispute this row
MARSHALL WACE, LLP Partly reported under another manager603,357 SH2,274,655 dollarsLower by 1,643,482 Prior quarter: 2,246,839Open filing 0001318757-26-000012 Filed 2026-11-13 Dispute this row
BANK OF AMERICA CORP /DE/ Partly reported under another manager581,011 SH2,190,411 dollarsLower by 231,048 Prior quarter: 812,059Open filing 0000070858-26-000589 Filed 2026-11-16 Dispute this row
ADAR1 Capital Management, LLC 551,918 SH2,080,731 dollarsHigher by 100,000 Prior quarter: 451,918Open filing 0001940272-26-000033 Filed 2026-11-16 Dispute this row
RENAISSANCE TECHNOLOGIES LLC Partly reported under another manager503,192 SH1,897,034 dollarsHigher by 445,392 Prior quarter: 57,800Open filing 0001037389-26-000062 Filed 2026-11-12 Dispute this row
Knott David M Jr Partly reported under another manager480,000 SH1,809,600 dollarsHigher by 29,000 Prior quarter: 451,000Open filing 0001104659-26-125757 Filed 2026-11-12 Dispute this row
CITADEL ADVISORS LLC Partly reported under another manager442,103 SH1,666,728 dollarsLower by 619,562 Prior quarter: 1,061,665Open filing 0001104659-26-128228 Filed 2026-11-16 Dispute this row
LOS ANGELES CAPITAL MANAGEMENT LLC 420,451 SH1,585,100 dollarsHigher by 264,738 Prior quarter: 155,713Open filing 0001177206-26-000010 Filed 2026-11-12 Dispute this row
HighVista Strategies LLC 419,299 SH1,580,757 dollarsLower by 26,500 Prior quarter: 445,799Open filing 0001172661-26-004983 Filed 2026-11-13 Dispute this row
D. E. Shaw Co., Inc. Partly reported under another manager418,387 SH1,577,319 dollarsHigher by 308,913 Prior quarter: 109,474Open filing 0001104659-26-128287 Filed 2026-11-16 Dispute this row
Birchview Capital, LP 408,100 SH1,538,537 dollarsUnchanged Prior quarter: 408,100Open filing 0001618205-26-000005 Filed 2026-11-13 Dispute this row
UBS Group AG Partly reported under another manager405,539 SH1,528,883 dollarsHigher by 247,506 Prior quarter: 158,033Open filing 0001610520-26-000121 Filed 2026-11-10 Dispute this row
PARSONS CAPITAL MANAGEMENT INC/RI 404,099 SH1,523,454 dollarsHigher by 50,030 Prior quarter: 354,069Open filing 0001018674-26-000006 Filed 2026-10-28 Dispute this row
BOOTHBAY FUND MANAGEMENT, LLC 372,300 SH1,403,571 dollarsLower by 192,459 Prior quarter: 564,759Open filing 0001549230-26-000012 Filed 2026-11-16 Dispute this row
Bank of New York Mellon Corp Partly reported under another manager361,922 SH1,364,446 dollarsHigher by 66,299 Prior quarter: 295,623Open filing 0001390777-26-000121 Filed 2026-11-05 Dispute this row
DIADEMA PARTNERS LP 361,367 SH1,362,354 dollarsUnchanged Prior quarter: 361,367Open filing 0001892688-26-000170 Filed 2026-11-16 Dispute this row
WELLINGTON MANAGEMENT GROUP LLP Partly reported under another manager336,070 SH1,266,984 dollarsHigher by 272,270 Prior quarter: 63,800Open filing 0000902219-26-000323 Filed 2026-11-16 Dispute this row
Woodline Partners LP 328,421 SH1,238,147 dollarsUnchanged Prior quarter: 328,421Open filing 0001172661-26-005063 Filed 2026-11-16 Dispute this row
SEVEN GRAND MANAGERS, LLC 315,788 SH1,190,521 dollarsUnchanged Prior quarter: 315,788Open filing 0001420506-26-002775 Filed 2026-11-16 Dispute this row
DEUTSCHE BANK AG\ Partly reported under another manager307,360 SH1,158,747 dollarsLower by 11,542 Prior quarter: 318,902Open filing 0000948046-26-000083 Filed 2026-11-06 Dispute this row
Managers in the prior quarter with no filing read for the latest

They may simply not have filed yet: absent from the latest quarter’s filings read is not the same as a position sold.

  • Jupiter Topco LLC 11,164,803 SH
  • Boxer Capital Management, LLC 842,106 SH
  • Soleus Capital Management, L.P. 842,106 SH
  • ACADIAN ASSET MANAGEMENT LLC 543,394 SH
  • Integral Health Asset Management, LLC 500,000 SH
  • Seven Fleet Capital Management LP 348,265 SH
  • Harvest Investment Services, LLC 340,890 SH
  • Sixth Street Partners Management Company, L.P. 282,717 SH
  • Informed Momentum Co LLC 88,447 SH
  • MANGROVE PARTNERS IM, LLC 71,705 SH
  • Belvedere Trading LLC 27,100 SH
  • INTECH INVESTMENT MANAGEMENT LLC 19,720 SH
  • AXQ CAPITAL, LP 12,093 SH
  • Scientech Research LLC 11,826 SH
  • World Investment Advisors 10,444 SH
  • MassMutual Private Wealth Trust, FSB 525 SH
  • Front Row Advisors LLC 2 SH
  • Form 13F covers long positions in Section 13(f) securities only: no short positions and no securities outside that list.
  • Reports for quarters ending before 2013-06-30 were filed as plain text and are not read.
  • A manager that has not yet filed for the latest quarter is absent, not at zero; filings are due up to 45 days after quarter end.
  • A change is the difference between two quarter-end snapshots, not a trade.
  • A position reported under another manager may also appear in that manager’s filing; rows are not added together.
  • Holdings the securities list cannot place with this company, or places ambiguously, are not shown.

Trades by members of Congress

Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.

Showing 1–2 of 2

House members’ trades in this company, newest report first, as filed
MemberTransaction dateTypeAmountOwnerReport
Hon. Christopher L. Jacobs (NY27)2022-12-12Sale$1,001 - $15,0002023-01-20
Hon. Christopher L. Jacobs (NY27)2022-11-08Purchase$1,001 - $15,0002022-12-12

5% holders (Schedule 13D and 13G)

Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.

5% holders, newest event first, as filed
HolderPercent of classShares heldEvent dateFormSource
Squadron Master Fund LP Common stock, $0.001 par value per share3.33,500,000.0009/30/2026 Filed 2026-11-16SCHEDULE 13G/AAmendment 4Open filing 0002050709-26-000032 Dispute this row
Squadron Capital Management LLC Common stock, $0.001 par value per share3.33,500,000.0009/30/2026 Filed 2026-11-16SCHEDULE 13G/AAmendment 4Open filing 0002050709-26-000032 Dispute this row
Matthew Sesterhenn Common stock, $0.001 par value per share3.33,500,000.0009/30/2026 Filed 2026-11-16SCHEDULE 13G/AAmendment 4Open filing 0002050709-26-000032 Dispute this row
William Blank Common stock, $0.001 par value per share3.33,500,000.0009/30/2026 Filed 2026-11-16SCHEDULE 13G/AAmendment 4Open filing 0002050709-26-000032 Dispute this row
Squadron Master Fund LP Common stock, $0.001 par value per share7.07,350,000.0006/30/2026 Filed 2026-08-14SCHEDULE 13G/AAmendment 3Open filing 0002050709-26-000025 Dispute this row
Squadron Capital Management LLC Common stock, $0.001 par value per share7.07,350,000.0006/30/2026 Filed 2026-08-14SCHEDULE 13G/AAmendment 3Open filing 0002050709-26-000025 Dispute this row
Matthew Sesterhenn Common stock, $0.001 par value per share7.07,350,000.0006/30/2026 Filed 2026-08-14SCHEDULE 13G/AAmendment 3Open filing 0002050709-26-000025 Dispute this row
William Blank Common stock, $0.001 par value per share7.07,350,000.0006/30/2026 Filed 2026-08-14SCHEDULE 13G/AAmendment 3Open filing 0002050709-26-000025 Dispute this row
BlackRock, Inc. Common Stock7.07,352,91306/30/2026 Filed 2026-07-29SCHEDULE 13GOpen filing 0002012383-26-002872 Dispute this row
Millennium Management LLC Common Stock, par value $0.001 per share4.44,567,952.0006/16/2026 Filed 2026-06-22SCHEDULE 13GOpen filing 0001104659-26-076490 Dispute this row
Millennium Group Management LLC Common Stock, par value $0.001 per share4.44,567,952.0006/16/2026 Filed 2026-06-22SCHEDULE 13GOpen filing 0001104659-26-076490 Dispute this row
Israel A. Englander Common Stock, par value $0.001 per share4.44,567,952.0006/16/2026 Filed 2026-06-22SCHEDULE 13GOpen filing 0001104659-26-076490 Dispute this row
Venrock Healthcare Capital Partners III, L.P. Common Stock, $0.001 par value per share6.26,508,433.0006/02/2026 Filed 2026-06-09SCHEDULE 13GOpen filing 0001738048-26-000066 Dispute this row
VHCP Co-Investment Holdings III, LLC Common Stock, $0.001 par value per share6.26,508,433.0006/02/2026 Filed 2026-06-09SCHEDULE 13GOpen filing 0001738048-26-000066 Dispute this row
Venrock Healthcare Capital Partners EG, L.P. Common Stock, $0.001 par value per share6.26,508,433.0006/02/2026 Filed 2026-06-09SCHEDULE 13GOpen filing 0001738048-26-000066 Dispute this row
VHCP Management III, LLC Common Stock, $0.001 par value per share6.26,508,433.0006/02/2026 Filed 2026-06-09SCHEDULE 13GOpen filing 0001738048-26-000066 Dispute this row
VHCP Management EG, LLC Common Stock, $0.001 par value per share6.26,508,433.0006/02/2026 Filed 2026-06-09SCHEDULE 13GOpen filing 0001738048-26-000066 Dispute this row
Nimish Shah Common Stock, $0.001 par value per share6.26,508,433.0006/02/2026 Filed 2026-06-09SCHEDULE 13GOpen filing 0001738048-26-000066 Dispute this row
Bong Y. Koh Common Stock, $0.001 par value per share6.26,508,433.0006/02/2026 Filed 2026-06-09SCHEDULE 13GOpen filing 0001738048-26-000066 Dispute this row
Commodore Capital LP Common stock, $0.001 par value per share5.15,505,527.0004/27/2026 Filed 2026-05-04SCHEDULE 13GOpen filing 0001831942-26-000017 Dispute this row
Commodore Capital Master LP Common stock, $0.001 par value per share5.15,505,527.0004/27/2026 Filed 2026-05-04SCHEDULE 13GOpen filing 0001831942-26-000017 Dispute this row
Robert Egen Atkinson Common stock, $0.001 par value per share5.15,505,527.0004/27/2026 Filed 2026-05-04SCHEDULE 13GOpen filing 0001831942-26-000017 Dispute this row
Michael Kramarz Common stock, $0.001 par value per share5.15,505,527.0004/27/2026 Filed 2026-05-04SCHEDULE 13GOpen filing 0001831942-26-000017 Dispute this row
Adage Capital Management, L.P. Common Stock, par value $0.001 per share4.544,763,158.0003/31/2026 Filed 2026-05-13SCHEDULE 13G/AAmendment 1Open filing 0000919574-26-002929 Dispute this row
Robert Atchinson Common Stock, par value $0.001 per share4.544,763,158.0003/31/2026 Filed 2026-05-13SCHEDULE 13G/AAmendment 1Open filing 0000919574-26-002929 Dispute this row
Phillip Gross Common Stock, par value $0.001 per share4.544,763,158.0003/31/2026 Filed 2026-05-13SCHEDULE 13G/AAmendment 1Open filing 0000919574-26-002929 Dispute this row
JANUS HENDERSON GROUP PLC Common Stock10.17,439,41501/30/2026 Filed 2026-02-06SCHEDULE 13GOpen filing 0001274173-26-000046 Dispute this row
Spruce Street Capital LP Common Stock, par value $0.001 per share5.574,086,181.0012/31/2025 Filed 2026-02-17SCHEDULE 13GOpen filing 0000902664-26-001027 Dispute this row
Alex R. Rosen Common Stock, par value $0.001 per share5.574,086,181.0012/31/2025 Filed 2026-02-17SCHEDULE 13GOpen filing 0000902664-26-001027 Dispute this row
Simon Basseyn Common Stock, par value $0.001 per share5.574,086,181.0012/31/2025 Filed 2026-02-17SCHEDULE 13GOpen filing 0000902664-26-001027 Dispute this row
Squadron Master Fund LP Common Stock ($.001 par value)9.97,395,510.0012/31/2025 Filed 2026-02-17SCHEDULE 13G/AAmendment 2Open filing 0002050709-26-000007 Dispute this row
Squadron Capital Management LLC Common Stock ($.001 par value)9.97,395,510.0012/31/2025 Filed 2026-02-17SCHEDULE 13G/AAmendment 2Open filing 0002050709-26-000007 Dispute this row
William Blank Common Stock ($.001 par value)9.97,395,510.0012/31/2025 Filed 2026-02-17SCHEDULE 13G/AAmendment 2Open filing 0002050709-26-000007 Dispute this row
Matthew Sesterhenn Common Stock ($.001 par value)9.97,395,510.0012/31/2025 Filed 2026-02-17SCHEDULE 13G/AAmendment 2Open filing 0002050709-26-000007 Dispute this row
Adage Capital Management, L.P. Common Stock, par value $0.001 per share5.824,270,000.0012/31/2025 Filed 2026-02-12SCHEDULE 13GOpen filing 0000902664-26-000914 Dispute this row
Robert Atchinson Common Stock, par value $0.001 per share5.824,270,000.0012/31/2025 Filed 2026-02-12SCHEDULE 13GOpen filing 0000902664-26-000914 Dispute this row
Phillip Gross Common Stock, par value $0.001 per share5.824,270,000.0012/31/2025 Filed 2026-02-12SCHEDULE 13GOpen filing 0000902664-26-000914 Dispute this row
Ikarian Capital, LLC Common Stock, par value $0.001 par value per share4.83,543,35909/30/2025 Filed 2025-11-14SCHEDULE 13GOpen filing 0001193125-25-283441 Dispute this row
Neil Shahrestani Common Stock, par value $0.001 par value per share4.83,543,35909/30/2025 Filed 2025-11-14SCHEDULE 13GOpen filing 0001193125-25-283441 Dispute this row
Squadron Master Fund LP Common Stock ($.001 par value)8.82,914,495.0006/30/2025 Filed 2025-08-14SCHEDULE 13G/AAmendment 1Open filing 0002050709-25-000005 Dispute this row
Squadron Capital Management LLC Common Stock ($.001 par value)9.93,298,500.0006/30/2025 Filed 2025-08-14SCHEDULE 13G/AAmendment 1Open filing 0002050709-25-000005 Dispute this row
William Blank Common Stock ($.001 par value)9.93,298,500.0006/30/2025 Filed 2025-08-14SCHEDULE 13G/AAmendment 1Open filing 0002050709-25-000005 Dispute this row

Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.

What was read

2,715,586 filings read, dated 2004-06-14 to 2026-11-20: Forms 3, 3/A, 4, 4/A, 5, 5/A.

Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.

Filings read, by filing year
Filing yearFilings read
2015131,968
2016222,642
2017222,009
2018223,345
2019216,482
2020226,343
2021249,835
2022231,682
2023229,674
2024234,045
2025235,520
2026263,828

Filings made before the SEC required XML are listed, not extracted.

Back to RELMADA THERAPEUTICS, INC.